ClassID:

92821

C07C235/06 - CPC Classification

Classification description:

Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton being acyclic and saturated having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms

Recent Application in this class:
#1
20260146239
2026-05-28

TERTIARY AMIDE ALDONAMIDE BASED ICE RECRYSTALLIZATION INHIBITOR COMPOUNDS AND COMPOSITIONS, AND USES THEREOF FOR CRYOPRESERVATION

#2
20250161227
2025-05-22

PEGYLATED LIPIDS

#3
20250152510
2025-05-15

LIPIDS AND LIPID NANOPARTICLE FORMULATIONS

#4
20250034081
2025-01-30

NOVEL LIPIDS AND LIPID NANOPARTICLE FORMULATIONS FOR DELIVERY OF NUCLEIC ACIDS

#5
20240398956
2024-12-05

BIODEGRADABLE LIPIDS FOR THE DELIVERY OF ACTIVE AGENTS

#6
20240285768
2024-08-29

BIODEGRADABLE LIPIDS FOR THE DELIVERY OF ACTIVE AGENTS

#7
20240285767
2024-08-29

Biodegradable lipids for the delivery of active agents

#8
20240269289
2024-08-15

BIODEGRADABLE LIPIDS FOR THE DELIVERY OF ACTIVE AGENTS

#9
20240269074
2024-08-15

LIPID COMPOUNDS AND LIPID NANOPARTICLE COMPOSITIONS

#10
20240261221
2024-08-08

POLYOL-MODIFIED LIPID COMPOUND AND PREPARATION METHOD AND APPLICATION THEREOF

#11
20240245778
2024-07-25

BIODEGRADABLE LIPIDS FOR THE DELIVERY OF ACTIVE AGENTS

#12
20240076195
2024-03-07

TASK-SPECIFIC IONIC LIQUIDS FOR SELECTIVE SEPARATION AND RECOVERY OF RARE EARTH ELEMENTS

#13
20230348361
2023-11-02

Ionizable lipid compounds

#14
20230256098
2023-08-17

BIODEGRADABLE LIPIDS FOR THE DELIVERY OF ACTIVE AGENTS

#15
20230233468
2023-07-27

Lipid compounds and lipid nanoparticle compositions

#16
20230112086
2023-04-13

Photo-cleavable primer compositions and methods of use

#17
20230103027
2023-03-30

Surface primer compositions and methods of use

#18
20220380300
2022-12-01

Alcohol derivatives as Kv7 potassium channel openers

#19
20220347302
2022-11-03

BIODEGRADABLE LIPIDS FOR THE DELIVERY OF ACTIVE AGENTS

#20
20220289660
2022-09-15

COMPOUNDS AND METHODS FOR DELIVERY OF PROSTACYCLIN ANALOGS

#21
20220259626
2022-08-18

Generation of acyl amino acids

#22
20220249670
2022-08-11

Biodegradable lipids for the delivery of active agents

#23
20220212945
2022-07-07

Task-specific ionic liquids for selective separation and recovery of rare earth elements

#24
20220175930
2022-06-09

Biodegradable lipids for the delivery of active agents

#25
20220175929
2022-06-09

Biodegradable lipids for the delivery of active agents

#26
20220175928
2022-06-09

Biodegradable lipids for the delivery of active agents

#27
20220125927
2022-04-28

Biodegradable lipids for the delivery of active agents

#28
20220111053
2022-04-14

Biodegradable lipids for the delivery of active agents

#29
20220105187
2022-04-07

Biodegradable lipids for the delivery of active agents

#30
20220024845
2022-01-27

Compounds and methods for delivery of prostacyclin analogs

#31
20220002229
2022-01-06

DIGLYCOLAMIDE DERIVATIVES FOR SEPARATION AND RECOVERY OF RARE EARTH ELEMENTS FROM AQUEOUS SOLUTIONS

#32
20210347749
2021-11-11

P62 ligand compound, and composition for preventing, ameliorating or treating proteinopathies comprising the same

#33
20210299253
2021-09-30

AUTOTAC chimeric compound, and composition for preventing, ameliorating or treating diseases through targeted protein degradation comprising the same

#34
20210284599
2021-09-16

Amide compounds, pharmaceutical compositions thereof, and methods of using the same

#35
20210198183
2021-07-01

Glycerol derivative, preparation method therefor, and immunomodulator comprising same as effective ingredient

#36
20210196584
2021-07-01

NOVEL COMPLEX AND EMULSION COMPOSITION

#37
20210179573
2021-06-17

Treatment of Multiple Sclerosis and Psoriasis Using Prodrugs of Methyl Hydrogen Fumarate

#38
20210163399
2021-06-03

NOVEL P62 LIGAND COMPOUND, AND COMPOSITION FOR PREVENTING, AMELIORATING OR TREATING PROTEINOPATHIES COMPRING THE SAME

#39
20210155589
2021-05-27

Method of preparing (3R,4S)-3-acetamido-4-allyl-n-(tert-butyl)pyrrolidine-3-carboxamide

#40
20210107861
2021-04-15

Lipids and lipid nanoparticle formulations for delivery of nucleic acids

#41
20210070690
2021-03-11

CATALYST FOR CONVERTING ESTER TO AMIDE USING HYDROXYL GROUP AS ORIENTATION GROUP

#42
20210062234
2021-03-04

Generation of acyl amino acids

#43
20200347248
2020-11-05

Photo-cleavable primer compositions and methods of use

#44
20200347247
2020-11-05

Surface primer compositions and methods of use

#45
20200181103
2020-06-11

Derivatives of sobetirome

#46
20200181066
2020-06-11

Adamantylmethylamine derivative and use thereof as pharmaceutical

#47
20200181057
2020-06-11

COMPOUNDS AND METHODS FOR DELIVERY OF PROSTACYCLIN ANALOGS

#48
20200172474
2020-06-04

Alcohol derivatives as KV7 potassium channel openers

#49
20200115322
2020-04-16

Method for producing n-benzyl-2-bromo-3-methoxypropionamide and intermediates thereof

#50
20200087272
2020-03-19

TREATMENT OF MULTIPLE SCLEROSIS AND PSORIASIS USING PRODRUGS OF METHYL HYDROGEN FUMARATE

#51
20200087255
2020-03-19

Method of preparing (3R,4S)-3-acetamido-4-allyl-n-(tert-butyl)pyrrolidine-3-carboxamide

#52
20200024222
2020-01-23

Hydrocarbon-containing carboxylic acid, hydrocarbon-containing sulfonic acid, hydrocarbon-containing sulfuric acid ester or salt thereof, and surfactant

#53
20190374646
2019-12-12

Biodegradable lipids for the delivery of active agents

#54
20190345091
2019-11-14

Compounds and methods for delivery of prostacyclin analogs

#55
20190270697
2019-09-05

Lipids and lipid nanoparticle formulations for delivery of nucleic acids

#56
20190256481
2019-08-22

Treatment of Multiple Sclerosis and Psoriasis Using Prodrugs of Methyl Hydrogen Fumarate

#57
20190256480
2019-08-22

Treatment of Multiple Sclerosis and Psoriasis Using Prodrugs of Methyl Hydrogen Fumarate

#58
20190256456
2019-08-22

Alcohol derivatives of carboxamides as Kv7 potassium channel openers

#59
20190248736
2019-08-15

Pseudo-ceramide compound and preparation method therefor

#60
20190161436
2019-05-30

Antibacterial agents

#61
20190119199
2019-04-25

Antibacterial agents

#62
20180362459
2018-12-20

Method of preparing (3R,4S)-3-acetamido-4-allyl-N-(tert-butyl)pyrrolidine-3-carboxamide

#63
20180340198
2018-11-29

Generation of acyl amino acids

#64
20180273500
2018-09-27

TREATMENT OF MULTIPLE SCLEROSIS AND PSORIASIS USING PRODRUGS OF METHYL HYDROGEN FUMARATE

#65
20180257044
2018-09-13

Process for making membranes

#66
20180237405
2018-08-23

TREATMENT OF MULTIPLE SCLEROSIS AND PSORIASIS USING PRODRUGS OF METHYL HYDROGEN FUMARATE

#67
20180230086
2018-08-16

Selected amide of Y-hydroxybutyric acid and uses thereof in the treatment of alcohol misuse

#68
20180187029
2018-07-05

COMPOSITION FOR FORMING HIGH RELEASE AND LOW FRICTION FUNCTIONAL COATINGS

#69
20180141966
2018-05-24

Chiral spiro phosphorus-nirogen-sulphur tridentate ligand, preparation method and application thereof

#70
20180141891
2018-05-24

COMPOUNDS AND METHODS FOR DELIVERY OF PROSTACYCLIN ANALOGS

#71
20180079713
2018-03-22

Thermal conversion vessel used in a process for amidification of acetone cyanohydrin

#72
20180057472
2018-03-01

Derivatives of sobetirome

#73
20170313648
2017-11-02

Pseudoceramide compound, and external use skin preparation composition containing same

#74
20170298009
2017-10-19

Method for the manufacture of N,N-dialkyllactamide

#75
20170217999
2017-08-03

Surface primer compositions and methods of use

#76
20170217997
2017-08-03

Photo-cleavable primer compositions and methods of use

#77
20170217878
2017-08-03

Antibacterial agents

#78
20170157268
2017-06-08

Lipids and lipid nanoparticle formulations for delivery of nucleic acids

#79
20160355464
2016-12-08

FUMARATE COMPOUNDS, PHARMACEUTICAL COMPOSITIONS THEREOF, AND METHODS OF USE

#80
20160355455
2016-12-08

Compounds and methods for delivery of prostacyclin analogs

#81
20160312005
2016-10-27

FATTY ACID DIAMIDES COMPRISING STEARIC HYDROXYACIDS AS ORGANOGELATORS

#82
20160244418
2016-08-25

Derivatives of sobetirome

#83
20160200669
2016-07-14

Method for recovering fluorinated emulsifier

#84
20160176811
2016-06-23

Amino acid derivatives

#85
20160130389
2016-05-12

POLYMERS PREPARED FROM MEVALONOLACTONE AND DERIVATIVES

#86
20160076065
2016-03-17

Generation of acyl amino acids

#87
20160060210
2016-03-03

Process for the preparation of lacosamide and its novel intermediate

#88
20160051505
2016-02-25

Compounds and methods for delivery of prostacyclin analogs

#89
20160031812
2016-02-04

Sepiapterin reductase inhibitors for the treatment of pain

#90
20160030371
2016-02-04

Compounds and methods for delivery of prostacyclin analogs

#91
20160024044
2016-01-28

Inhibiting neurotransmitter reuptake

#92
20160024042
2016-01-28

Prodrugs of Fluorinated Mevalonates to Inhibit the Mevalonate Pathway of Streptococcus pneumoniae

#93
20150274644
2015-10-01

14-HYDROXYEICOSANOIC ACID-BASED FATTY ACID AMIDE, AS AN ORGANOGELLING AGENT

#94
20150273068
2015-10-01

Biodegradable lipids for the delivery of active agents

#95
20150259317
2015-09-17

Protected succinates for enhancing mitochondrial ATP-production

#96
20150259274
2015-09-17

Compounds and methods for delivery of prostacyclin analogs

#97
20150252013
2015-09-10

TREATMENT OF MULTIPLE SCLEROSIS AND PSORIASIS USING PRODRUGS OF METHYL HYDROGEN FUMARATE

#98
20150250792
2015-09-10

Alpha hydroxy amides

#99
20150208645
2015-07-30

PHYTOSANITARY COMPOSITIONS COMPRISING AN ETHER-AMIDE COMPOUND

#100
20150197486
2015-07-16

METHODS OF USING PRODRUGS OF METHYL HYDROGEN FUMARATE AND PHARMACEUTICAL COMPOSITIONS THEREOF

#101
20150073049
2015-03-12

Crystalline forms of (N,N-Diethylcarbamoyl)methyl methyl (2E)but-2-ene-1,4-dioate, methods of synthesis and use

#102
20150005374
2015-01-01

Compounds and methods for delivery of prostacyclin analogs

#103
20140364648
2014-12-11

Ether-amide compounds and preparation and uses thereof

#104
20140336194
2014-11-13

METHOD OF TREATING CONTRAST-INDUCED NEPHROPATHY

#105
20140329818
2014-11-06

Methods of using prodrugs of methyl hydrogen fumarate and pharmaceutical compositions thereof

#106
20140309273
2014-10-16

Compounds and methods of treating obesity

#107
20140235718
2014-08-21

Phenoxyethoxy compounds

#108
20140228430
2014-08-14

Method of Accelerating Corneal Wound Healing

#109
20140200257
2014-07-17

PEGylated lipids and their use for drug delivery

#110
20140171388
2014-06-19

Compound for treating cartilage disorders

#111
20140134282
2014-05-15

Nitrooxy alkanoic acids and derivatives thereof in feed for reducing methane emission in ruminants, and/or to improve ruminant performance

#112
20130261187
2013-10-03

Compounds and methods for delivery of prostacyclin analogs

#113
20130245284
2013-09-19

Prodrugs of fluorinated mevalonates to inhibit the mevalonate pathway of

#114
20130195920
2013-08-01

Biodegradable lipids for the delivery of active agents

#115
20130123534
2013-05-16

Method for synthesizing rare earth metal extractant

#116
20130123522
2013-05-16

Process for preparation of lacosamide and some N-benzyl-propanamide intermediate derivatives

#117
20130102806
2013-04-25

Method for synthesizing rare earth metal extractant

#118
20130053342
2013-02-28

Hydroxylated amide skin moisturizer

#119
20130041179
2013-02-14

Amide compound production catalyst, and process for production of amide compound

#120
20120322800
2012-12-20

Sepiapterin reductase inhibitors for the treatment of pain

#121
20120315339
2012-12-13

Nitrooxy alkanoic acids and derivatives thereof in feed for reducing methane emission in ruminants, and/or to improve ruminant performance

#122
20120302791
2012-11-29

Ether-amide compounds and uses thereof

#123
20120295980
2012-11-22

Compounds and methods for delivery of prostacyclin analogs

#124
20120253042
2012-10-04

Use of ruthenium complexes for formation and/or hydrogenation of amides and related carboxylic acid derivatives

#125
20120245384
2012-09-27

Method of preparing highly fluorinated carboxylic acids and their salts

#126
20120157523
2012-06-21

Prodrugs of methyl hydrogen fumarate, pharmaceutical compositions thereof, and methods of use

#127
20120136074
2012-05-31

Systems and methods employing low molecular weight gelators for crude oil, petroleum product or chemical spill containment and remediation

#128
20120122844
2012-05-17

Method of treating contrast-induced nephropathy

#129
20120095003
2012-04-19

Methods of using prodrugs of methyl hydrogen fumarate and pharmaceutical compositions thereof

#130
20120015909
2012-01-19

MAO-B INHIBITORS USEFUL FOR TREATING OBESITY

#131
20120015089
2012-01-19

Geranylamine derivatives as flavouring agents

#132
20120004459
2012-01-05

Synthesis of rare earth metal extractant

#133
20120004458
2012-01-05

Synthesis of rare earth metal extractant

#134
20110318542
2011-12-29

Fluorine-containing compound, fluorine-containing polymer compound, resist composition and patterning method using same

#135
20110269652
2011-11-03

GEMINI SURFACTANTS

#136
20110263898
2011-10-27

Ether-amide compounds and preparation and uses thereof

#137
20110251430
2011-10-13

Method for producing β-alkoxypropionamide

#138
20110251294
2011-10-13

Fast recovery of thixotropy by organogels with low molecular weight gelators

#139
20110207809
2011-08-25

METHOD OF ACCELERATING CORNEAL WOUND HEALING

#140
20110178339
2011-07-21

Process for manufacturing N, N-dialkyl lactamide

#141
20110178151
2011-07-21

COMPOUNDS AND METHODS OF TREATING OBESITY

#142
20110130350
2011-06-02

Synthesis scheme for lacosamide

#143
20110118213
2011-05-19

Compounds and methods for delivery of prostacyclin analogs

#144
20110089021
2011-04-21

Method For Producing Amides In The Presence Of Superheated Water

#145
20110083957
2011-04-14

Continuous Method For Producing Amides Of Aliphatic Hydroxycarboxylic Acids

#146
20110060159
2011-03-10

Process for preparing carboxamides by hydrolysis carboxylic acid nitriles in the presence of a catalyst comprising manganese dioxide

#147
20110046411
2011-02-24

Process for the preparation of intermediates useful in the synthesis of statin derivatives

#148
20110034728
2011-02-10

Catalyst for reacting carboxylic acid nitriles

#149
20100294722
2010-11-25

Boron removal method utilizing sugar amide derivative

#150
20100280076
2010-11-04

Derivatives of dioxan-2-alkyl carbamates, preparation thereof and application thereof in therapeutics

#151
20100279959
2010-11-04

Medium-chain length fatty acids, glycerides and analogues as neutrophil survival and activation factors

#152
20100261797
2010-10-14

Polymorphic forms of N-[4-(trifluoromethyl)benzyl]-4-methoxybutyramide

#153
20100217020
2010-08-26

Process for producing vitamin D derivative using convergent method

#154
20100185007
2010-07-22

PROCESS FOR PREPARING FLUOROAMIDE AND FLUORONITRILE

#155
20100168068
2010-07-01

MAO-B inhibitors useful for treating obesity

#156
20100158996
2010-06-24

ESTER COMPOUND AND MEDICAL USE THEREOF

#157
20100145048
2010-06-10

Compounds for the treatment of inflammatory disorders

#158
20100076223
2010-03-25

Method for producing a β-alkoxypropionamide

#159
20100048651
2010-02-25

Prodrugs of methyl hydrogen fumarate, pharmaceutical compositions thereof, and methods of use

#160
20100009933
2010-01-14

Hydroxylated amide skin moisturizer

#161
20090286868
2009-11-19

Derivatives of dioxan-2-alkyl carbamates, preparation thereof and application thereof in therapeutics

#162
20090258884
2009-10-15

Substituted amides

#163
20090227453
2009-09-10

Formulations

#164
20090221853
2009-09-03

Process for the preparation of 2-chloroethoxy-acetic acid--dimethylamide

#165
20090082587
2009-03-26

Process for chemical reactions involving cyanohydrins

#166
20090036301
2009-02-05

Process for producing catalyst for cyanhydrin hydration and product of the process

#167
20090030231
2009-01-29

Process of preparing optically active β-hydroxycarboxylic acid derivative

#168
20080318976
2008-12-25

Alpha-hydroxy amides as bradykinin antagonists or inverse agonists

#169
20080312466
2008-12-18

Process for the preparation of intermediates useful in the synthesis of statin derivatives especially 7-amino-3.5-dihydroxyhepanoic acid derivatives and intermediates thereof

#170
20080255346
2008-10-16

Ratiometric fluorescent chemosensor for selective detection of Hg (II) ions

#171
20080249167
2008-10-09

Compounds and methods for delivery of prostacyclin analogs

#172
20080171692
2008-07-17

Substituted pyridyoxy amides

#173
20080161580
2008-07-03

PROTECTED 3,5-DIHYDROXY-2,2-DIMETHYL-VALEROAMIDES FOR THE SYNTHESIS OF EPOTHILONES AND DERIVATIVES AND PROCESS FOR THE PRODUCTION AND THE USE

#174
20080145320
2008-06-19

Antimicrobial compositions

#175
20080125601
2008-05-29

Process for the preparation of 7-amino syn 3,5-dihydroxy heptanoic acid derivatives, intermediates thereof and methods for their preparation

#176
20080119556
2008-05-22

Geranyl compounds

#177
20080113939
2008-05-15

Mevalonic acid derivatives

#178
20080027137
2008-01-31

Synthesis scheme for lacosamide

#179
20070167426
2007-07-19

Compounds for the treatment of inflammatory disorders and microbial diseases

#180
20070155813
2007-07-05

Hsp90 family protein inhibitors

#181
20070142662
2007-06-21

Process for the preparation of 7-amino syn 3,5-dihydroxy heptanoic acid derivatives via 6-cyano syn 3,5-dihydroxy hexanoic acid derivatives

#182
20070142333
2007-06-21

CYCLOALKYL INHIBITORS OF POTASSIUM CHANNEL FUNCTION

#183
20070129378
2007-06-07

Compounds for the treatment of inflammatory disorders and microbial diseases

#184
20070105949
2007-05-10

Intermediates for the preparation of lipoxin Aanalogs

#185
20070088004
2007-04-19

MAO-B inhibitors useful for treating obesity

#186
20070082948
2007-04-12

Compounds and methods for delivery of prostacyclin analogs

#187
20070078182
2007-04-05

Compounds and methods for delivery of prostacyclin analogs

#188
20070078095
2007-04-05

Compounds and methods for delivery of prostacyclin analogs

#189
20070037864
2007-02-15

Intermediates for the preparation of lipoxin Aanalogs

#190
20070004683
2007-01-04

MAO-B inhibitors useful for treating obesity

#191
20060252778
2006-11-09

Compounds for the treatment of inflammatory disorders

#192
20060247290
2006-11-02

DERIVATIVES OF DIOXAN-2-ALKYL CARBAMATES, PREPARATION THEREOF AND APPLICATION THEREOF IN THERAPEUTICS

#193
20060247274
2006-11-02

Substituted amino acids as erythropoietin mimetics

#194
20060178366
2006-08-10

Compounds for the treatment of inflammatory disorders

#195
20060177919
2006-08-10

Process for the preparation of (S)- or (R)-3,3,3-trifluoro-2-hydroxy-2-methylpropionic acid

#196
20060142244
2006-06-29

Geranyl compounds

#197
20060111586
2006-05-25

Process for chemical reactions involving cyanohydrins

#198
20060111406
2006-05-25

Amide linker peroxisome proliferator activated receptor modulators

#199
20050282901
2005-12-22

Compounds and methods for delivery of prostacyclin analogs

#200
20050272731
2005-12-08

Protected 3,5-dihydroxy-2,2-dimethyl-valeroamides for the synthesis of epothilones and derivatives and process for production and the use

#201
20050234106
2005-10-20

Cycloalkyl inhibitors of potassium channel function

#202
20050234061
2005-10-20

Substituted amides

#203
20050182235
2005-08-18

Methods of making intermediates from polyhydroxyalkanoates

#204
20050182130
2005-08-18

Derivatives of dioxane-2-alkyl carbamates, preparation thereof and application thereof in therapeutics

#205
20050119474
2005-06-02

Geranyl compounds

#206
20050101760
2005-05-12

Methods of making intermediates from polyhydroxyalkanoates

#207
20050085540
2005-04-21

Compounds and methods for delivery of prostacyclin analogs

#208
20050075367
2005-04-07

Ester compound and medicinal use thereof

#209
20050033086
2005-02-10

Process for the preparation of 7-amino syn 3,5-dihydroxy heptanoic acid derivatives via 6-cyano syn 3,5-dihydroxy hexanoic acid derivatives

#210
17302311
2022-02-15

Biodegradable lipids for the delivery of active agents